OKYO Pharma’s Urcosimod Receives FDA Fast Track for Neuropathic Corneal Pain Treatment
OKYO Pharma’s investigational drug urcosimod has received FDA Fast Track designation for treating neuropathic corneal pain, a chronic and severe ocular condition with no FDA-approved therapy.
2 minutes to read